Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

References for PMC Articles for PubMed (Select 19279439)

1.

Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field.

Pfaendler KS, Mwanahamuntu MH, Sahasrabuddhe VV, Mudenda V, Stringer JS, Parham GP.

Gynecol Oncol. 2008 Sep;110(3):402-7. doi: 10.1016/j.ygyno.2008.04.031. Epub 2008 Jun 16.

2.

Zambia's health-worker crisis.

Bowa K.

Lancet. 2008 May 10;371(9624):1577-8. doi: 10.1016/S0140-6736(08)60686-8. No abstract available.

PMID:
18468538
3.

Rapid expansion of the health workforce in response to the HIV epidemic.

Samb B, Celletti F, Holloway J, Van Damme W, De Cock KM, Dybul M.

N Engl J Med. 2007 Dec 13;357(24):2510-4. No abstract available.

PMID:
18077816
4.

Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial.

Sankaranarayanan R, Esmy PO, Rajkumar R, Muwonge R, Swaminathan R, Shanthakumari S, Fayette JM, Cherian J.

Lancet. 2007 Aug 4;370(9585):398-406.

PMID:
17679017
5.

Non-physician clinicians in 47 sub-Saharan African countries.

Mullan F, Frehywot S.

Lancet. 2007 Dec 22;370(9605):2158-63.

PMID:
17574662
6.

Effectiveness, safety and acceptability of 'see and treat' with cryotherapy by nurses in a cervical screening study in India.

Sankaranarayanan R, Rajkumar R, Esmy PO, Fayette JM, Shanthakumary S, Frappart L, Thara S, Cherian J.

Br J Cancer. 2007 Mar 12;96(5):738-43. Epub 2007 Feb 20.

7.

Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.

Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, Mtonga V, Reid S, Cantrell RA, Bulterys M, Saag MS, Marlink RG, Mwinga A, Ellerbrock TV, Sinkala M.

JAMA. 2006 Aug 16;296(7):782-93.

PMID:
16905784
8.

The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings.

Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y, Sutherland D, Vitoria M, Guerma T, De Cock K.

Lancet. 2006 Aug 5;368(9534):505-10.

PMID:
16890837
9.

Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia.

Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, Stringer EM, Vermund SH.

Gynecol Oncol. 2006 Dec;103(3):1017-22. Epub 2006 Jul 27.

10.

Worldwide burden of gynaecological cancer: the size of the problem.

Sankaranarayanan R, Ferlay J.

Best Pract Res Clin Obstet Gynaecol. 2006 Apr;20(2):207-25. Epub 2005 Dec 13. Review.

PMID:
16359925
11.

Cost-effectiveness of cervical-cancer screening in five developing countries.

Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mahé C, Wright TC; Alliance for Cervical Cancer Prevention Cost Working Group.

N Engl J Med. 2005 Nov 17;353(20):2158-68.

12.

Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial.

Denny L, Kuhn L, De Souza M, Pollack AE, Dupree W, Wright TC Jr.

JAMA. 2005 Nov 2;294(17):2173-81.

PMID:
16264158
13.

Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.

Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, Hall C, Bacon M, Levine AM, Watts DH, Silverberg MJ, Xue X, Schlecht NF, Melnick S, Palefsky JM.

J Natl Cancer Inst. 2005 Apr 20;97(8):577-86.

14.

A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India.

Sankaranarayanan R, Nene BM, Dinshaw KA, Mahe C, Jayant K, Shastri SS, Malvi SG, Chinoy R, Kelkar R, Budukh AM, Keskar V, Rajeshwarker R, Muwonge R, Kane S, Parkin DM, Chauhan MK, Desai S, Fontaniere B, Frappart L, Kothari A, Lucas E, Panse N; Osmanabad District Cervical Screening Study Group.

Int J Cancer. 2005 Sep 10;116(4):617-23.

PMID:
15818610
15.

Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results.

Harris TG, Burk RD, Palefsky JM, Massad LS, Bang JY, Anastos K, Minkoff H, Hall CB, Bacon MC, Levine AM, Watts DH, Silverberg MJ, Xue X, Melnick SL, Strickler HD.

JAMA. 2005 Mar 23;293(12):1471-6.

PMID:
15784870
16.

Global cancer statistics, 2002.

Parkin DM, Bray F, Ferlay J, Pisani P.

CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108.

PMID:
15761078
17.

Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa.

Sankaranarayanan R, Basu P, Wesley RS, Mahe C, Keita N, Mbalawa CC, Sharma R, Dolo A, Shastri SS, Nacoulma M, Nayama M, Somanathan T, Lucas E, Muwonge R, Frappart L, Parkin DM; IARC Multicentre Study Group on Cervical Cancer Early Detection.

Int J Cancer. 2004 Jul 20;110(6):907-13.

PMID:
15170675
18.

The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases.

Heard I, Palefsky JM, Kazatchkine MD.

Antivir Ther. 2004 Feb;9(1):13-22. Review.

PMID:
15040532
19.

Cervical cancer control, priorities and new directions.

Monsonego J, Bosch FX, Coursaget P, Cox JT, Franco E, Frazer I, Sankaranarayanan R, Schiller J, Singer A, Wright TC Jr, Kinney W, Meijer CJ, Linder J, McGoogan E, Meijer C.

Int J Cancer. 2004 Jan 20;108(3):329-33. Erratum in: Int J Cancer. 2004 Mar 1;108(6):945. Wright Tom [corrected to Wright Thomas C Jr]; Meijer Chris [corrected to Meijer Chris J L M].

PMID:
14648697
20.

Can screening for cervical cancer be improved, especially in developing countries?

Miller AB, Sankaranarayanan R, Bosch FX, Sepulveda C.

Int J Cancer. 2003 Nov 10;107(3):337-40. Review. No abstract available.

PMID:
14506730
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk